Celebrating 25+ years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

Ovarian Cancer Research Alliance

CharityWatch report issued
April 2019

Top-Rated Charity
A
CharityWatch Grade
Our independent grade based
on a number of factors.
 
81%
Program Percentage
Amount spent on programs
relative to overhead.
 
$12
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

Ovarian Cancer Research Alliance
14 Pennsylvania Plaza
Suite 2110
New York, NY 10122

Other Names

OCRF
OCRFA
Ovarian Cancer National Alliance
Ovarian Cancer Research Fund
Ovarian Cancer Research Fund Alliance

Tax Status

501(c)3

Stated Mission

To cure ovarian cancer, advocate for patients, and support survivors.

View similar charities
Charity  
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Research Foundation  
Breast Cancer Society (DISSOLVED)  
Cancer Care  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Research Institute  
Cancer Survivors' Fund  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation  
Children's Cancer Research Fund  
CureSearch for Children's Cancer  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation  
Good Charity  
Leukemia & Lymphoma Society  
LiveStrong Foundation  
Memorial Sloan Kettering Cancer Center  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Cancer Assistance Foundation  
National Cancer Center  
National Cancer Coalition (DISSOLVED)  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Pancreatic Cancer Action Network  
Prevent Cancer Foundation  
Prostate Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 12/31/2017

Program Percentage: 81%

The percentage of Ovarian Cancer Research Alliance's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).

$11,000,000

Calculated Total Expenses

(rounded)

 

Cost to Raise $100: $12

How many dollars Ovarian Cancer Research Alliance spends on fundraising to raise each $100 of contributions.

$9,100,000

Calculated Total Contributions

(rounded)

Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources

 

Financial Documents

Entity Document Type Tax ID
Ovarian Cancer Research Fund Alliance Audited Consolidated Financial Statements 13-3806788
Ovarian Cancer Research Fund Alliance IRS Form 990 13-3806788
Entity: Ovarian Cancer Research Fund Alliance
Document Type: Audited Consolidated Financial Statements
Tax ID: 13-3806788
Entity: Ovarian Cancer Research Fund Alliance
Document Type: IRS Form 990
Tax ID: 13-3806788

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
 
Ovarian Cancer Research Alliance
meets governance benchmarks.
 
Ovarian Cancer Research Alliance
meets transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy No Sharing  

  Name Title Compensation
1 Audra L. Moran President/CEO $289,068
2 Jonathan Zeidman VP, Development $164,025
3 Roberta Franklin VP, Marketing & Communications $159,929
1
Name: Audra L. Moran
Title: President/CEO
Compensation: $289,068
2
Name: Jonathan Zeidman
Title: VP, Development
Compensation: $164,025
3
Name: Roberta Franklin
Title: VP, Marketing & Communications
Compensation: $159,929

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
According to the Ovarian Cancer Research Fund Alliance consolidated audit of December 31, 2017 (Note 1, Nature of Operations):

"The Ovarian Cancer Research Fund, Inc. D/B/A Ovarian Cancer Research Fund Alliance ('OCRFA') is a corporation which was organized in the State of New York as a not-for-profit entity on December 8, 1994. OCRFA previously operated as the Ovarian Cancer Research Fund, Inc. ('OCRF'), and adopted its present name on January 1, 2016, the date on which the operations of the Ovarian Cancer National Alliance ('OCNA') were merged with OCRF's by the transfer of all of the operating assets and liabilities of OCNA to OCRFA. As a result of the transaction, OCRFA acquired, on a consolidated basis, net assets of $992,635, of which $348,020 were temporarily restricted."


CharityWatch's rating of Ovarian Cancer Research Alliance for the fiscal year ended 12/31/17 is based on the financial activities of the consolidated entity that resulted from the merger between OCRF and OCNA.
According to the Ovarian Cancer Research Fund Alliance consolidated audit of December 31, 2017 (Note 2, Concentrations of Credit Risk):

"Included in the contributions of $6,526,826 for the year ended December 31, 2017 is a donation from the late Sol Schreiber, the founder of OCRF [Ovarian Cancer Research Fund], totaling approximately $1,300,000." [The $1,300,000 is about 20% of $6,526,826.]
According to the Ovarian Cancer Research Fund Alliance consolidated audit of December 31, 2017 (Note 1, Contributed Services), the Alliance received in-kind contributed services in 2017 for "advertising services and professional fees" on which it placed a total value of $539,382.

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

Related External Articles